Politicians and people with souls agree: The Pfizer-Allergan merger is reprehensible
The Pfizer-Allergan deal is being masqueraded as a means to improve patient access to cutting edge medicine - but at core it's a clear inversion deal, conducted to line shareholders' pockets.